Translation of "95% confidence interval" in German
																						The
																											rate
																											(95%
																											confidence
																											interval)
																											of
																											lymphomas
																											was
																											0.7
																											(0.2,
																											2.7)
																											per
																											1,000
																											patient-years
																											among
																											adalimumab-treated
																											patients
																											and
																											0.6
																											(0.1,
																											4.5)
																											per
																											1,000
																											patient-years
																											among
																											control
																											patients.
																		
			
				
																						Die
																											Rate
																											(95
																											%
																											Konfidenzintervall)
																											für
																											Lymphome
																											betrug
																											0,7
																											(0,2;
															 
				
		 ELRC_2682 v1
			
																						The
																											rate
																											(95
																											%
																											confidence
																											interval)
																											of
																											lymphomas
																											was
																											0.7
																											(0.2,
																											2.7)
																											per
																											1,000
																											patient-years
																											among
																											adalimumab-treated
																											patients
																											and
																											0.6
																											(0.1,
																											4.5)
																											per
																											1,000
																											patient-years
																											among
																											control
																											patients.
																		
			
				
																						Die
																											Rate
																											(95-%-Konfidenzintervall)
																											für
																											Lymphome
																											betrug
																											0,7
																											(0,2;
															 
				
		 ELRC_2682 v1
			
																						The
																											rate
																											(95%
																											confidence
																											interval)
																											of
																											non-melanoma
																											skin
																											cancers
																											was
																											8.8
																											(6.0,
																											13.0)
																											per
																											1,000
																											patient-years
																											among
																											adalimumab-treated
																											patients
																											and
																											3.2
																											(1.3,
																											7.6)
																											per
																											1,000
																											patient-years
																											among
																											control
																											patients.
																		
			
				
																						Die
																											Rate
																											(95-%-Konfidenzintervall)
																											nicht
																											melanomartiger
																											Hauttumoren
																											betrug
																											8,8
																											(6,0;
															 
				
		 ELRC_2682 v1
			
																						The
																											rate
																											(95
																											%
																											confidence
																											interval)
																											of
																											lymphomas
																											was
																											0.7
																											(0.2,
																											2.7)
																											per
																											1,000
																											patient-years
																											among
																											adalimumab-treated
																											patients
																											and
																											0.6
																											(0.1,
																											4.5)
																											per
																											1,000
																											patient-years
																											among
																		
			
				
																						Die
																											Rate
																											(95
																											%-Konfidenzintervall)
																											für
																											Lymphome
																											betrug
																											0,7
																											(0,2;
															 
				
		 ELRC_2682 v1
			
																						The
																											odds
																											ratio
																											(95%
																											exact
																											confidence
																											interval)
																											was
																											2.96
																											(1.34,
																											7.50).
																		
			
				
																						Die
																											Odds-Ratio
																											(95%
																											bestimmtes
																											Konfidenzintervall)
																											betrug
																											2,96
																											(1,34;
															 
				
		 ELRC_2682 v1
			
																						The
																											rate
																											(95
																											%
																											confidence
																											interval)
																											of
																											lymphomas
																											was
																											0.7
																											(0.2,
																											2.7)
																											per
																											1,000
																											patient
																											years
																											among
																											adalimumab-treated
																											patients
																											and
																											0.6
																											(0.1,
																											4.5)
																											per
																											1,000
																											patient
																											years
																											among
																											control
																											patients.
																		
			
				
																						Die
																											Rate
																											(95
																											%
																											Konfidenzintervall)
																											für
																											Lymphome
																											betrug
																											0,7
																											(0,2;
															 
				
		 ELRC_2682 v1
			
																						The
																											rate
																											(95%
																											confidence
																											interval)
																											of
																											lymphomas
																											was
																											0.7
																											(0.2,
																											2.7)
																											per
																											1,000
																											patient-years
																											among
																											Humira-treated
																											patients
																											and
																											0.6
																											(0.1,
																											4.5)
																											per
																											1,000
																											patient-years
																											among
																											control
																											patients.
																		
			
				
																						Die
																											Rate
																											(95
																											%
																											Konfidenzintervall)
																											für
																											Lymphome
																											betrug
																											0,7
																											(0,2;
															 
				
		 ELRC_2682 v1
			
																						The
																											odds
																											ratio
																											(95%
																											exact
																											confidence
																											interval)
																											was
																											1.21
																											(0.7,
																											2.1).
																		
			
				
																						Die
																											Odds-Ratio
																											(95
																											%
																											Konfidenzintervall)
																											betrug
																											1,21
																											(0,7;
															 
				
		 ELRC_2682 v1
			
																						It
																											is
																											also
																											recommended
																											to
																											calculate
																											the
																											95
																											%
																											confidence
																											interval
																											of
																											the
																											mean
																											value.
																		
			
				
																						Ferner
																											wird
																											empfohlen,
																											das
																											95
																											%-Konfidenzniveau
																											für
																											den
																											Mittelwert
																											zu
																											berechnen.
															 
				
		 DGT v2019
			
																						Thus,
																											for
																											each
																											indicator
																											we
																											shall
																											determine
																											a
																											95%
																											confidence
																											interval.
																		
			
				
																						Für
																											jeden
																											Indikator
																											wird
																											ein
																											Vertrauensintervall
																											von
																											95
																											%
																											festgelegt.
															 
				
		 EUbookshop v2
			
																						All
																											results
																											for
																											continuous
																											variables
																											were
																											expressed
																											as
																											medians
																											with
																											95%
																											confidence
																											interval.
																		
			
				
																						Alle
																											Ergebnisse
																											für
																											kontinuierliche
																											Variablen
																											werden
																											als
																											Mediane
																											mit
																											95%
																											Vertrauensintervall
																											ausgedrückt.
															 
				
		 EuroPat v2
			
																						The
																											color
																											legend
																											designates
																											the
																											95%
																											confidence
																											interval
																											(in
																											percent
																											of
																											1).
																		
			
				
																						Die
																											Farbenlegende
																											bezeichnet
																											das
																											95%-ige
																											Vertrauensintervall
																											(in
																											Prozent
																											von
																											1).
															 
				
		 EuroPat v2
			
																						Error
																											bars
																											represent
																											95%
																											confidence
																											interval
																											of
																											the
																											mean
																											(n
																											=
																											6).
																		
			
				
																						Fehlerbalken
																											stellen
																											95%
																											-Konfidenzintervall
																											des
																											Mittelwertes
																											(n
																											=
																											6).
															 
				
		 ParaCrawl v7.1
			
																						Figure
																											1
																											shows
																											the
																											equivalent
																											reference
																											hearing
																											thresholds
																											for
																											the
																											DD65v2
																											headphone
																											as
																											mean
																											values
																											with
																											a
																											95%
																											confidence
																											interval.
																		
			
				
																						Abbildung
																											1
																											zeigt
																											die
																											äquivalenten
																											Bezugshörschwellen
																											für
																											den
																											DD65v2-Kopfhörer
																											als
																											Mittelwerte
																											mit
																											95%-Konfidenzintervall.
															 
				
		 ParaCrawl v7.1
			
																						The
																											rate
																											(95%
																											confidence
																											interval)
																											of
																											nonmelanoma
																											skin
																											cancers
																											was
																											8.8
																											(6.0,
																											13.0)
																											per
																											1,000
																											patient-years
																											among
																											adalimumab-treated
																											patients
																											and
																											3.2
																											(1.3,
																											7.6)
																											per
																											1,000
																											patient-years
																											among
																											control
																											patients.
																		
			
				
																						Die
																											Rate
																											(95
																											%
																											Konfidenzintervall)
																											nicht
																											melanomartiger
																											Hauttumoren
																											betrug
																											8,8
																											(6,0;
															 
				
		 ELRC_2682 v1
			
																						The
																											INCAT
																											responder
																											rate
																											was
																											60.7%
																											(95%
																											confidence
																											interval
																											[42.41,
																											76.4]).
																		
			
				
																						Die
																											INCAT-Ansprechrate
																											betrug
																											60,7
																											%
																											(95%
																											Konfidenzintervall
																											[42,41,
																											76,4]).
															 
				
		 ELRC_2682 v1
			
																						Of
																											these
																											skin
																											cancers,
																											squamous
																											cell
																											carcinomas
																											occurred
																											at
																											rates
																											(95%
																											confidence
																											interval)
																											of
																											2.7
																											(1.4,
																											5.4)
																											per
																											1,000
																											patient-years
																											among
																											adalimumab-treated
																											patients
																											and
																											0.6
																											(0.1,
																											4.5)
																											per
																											1,000
																											patient-years
																											among
																											control
																											patients.
																		
			
				
																						Bei
																											diesen
																											Hauttumoren
																											traten
																											Plattenepithelkarzinome
																											mit
																											einer
																											Rate
																											(95-%-Konfidenzintervall)
																											von
																											2,7
																											(1,4;
															 
				
		 ELRC_2682 v1
			
																						The
																											adjusted
																											treatment
																											difference
																											and
																											95%
																											confidence
																											interval
																											have
																											been
																											back
																											transformed
																											from
																											log
																											transformed
																											data.
																		
			
				
																						Der
																											bereinigte
																											Behandlungsunterschied
																											und
																											das
																											95
																											%
																											Konfidenzintervall
																											wurden
																											von
																											log-transformierten
																											Daten
																											zurück
																											transformiert.
															 
				
		 ELRC_2682 v1
			
																						The
																											rate
																											(95%
																											confidence
																											interval)
																											of
																											non-melanoma
																											skin
																											cancers
																											was
																											7.6
																											(4.7,
																											12.4)
																											per
																											1000
																											patient-years
																											among
																											Trudexa-treated
																											patients
																											and
																											2.0
																											(0.5,
																											8.2)
																											per
																											1000
																											patient-years
																											among
																											control
																											patients.
																		
			
				
																						Die
																											Rate
																											(95
																											%
																											Konfidenzintervall)
																											von
																											nicht-melanomartigen
																											Hauttumoren
																											betrug
																											7,6
																											(4,7;
															 
				
		 ELRC_2682 v1
			
																						The
																											washout
																											period
																											is
																											up
																											to
																											24
																											weeks
																											(95%
																											confidence
																											interval,
																											18-24
																											weeks)
																		
			
				
																						Die
																											Auswaschperiode
																											beträgt
																											bis
																											zu
																											24
																											Wochen
																											(95
																											%-Konfidenzintervall
																											18
																											-
																											24
																											Wochen).
															 
				
		 EMEA v3